Comment on CMS-2026-2212-0001
BIOSupportTrade association
Summary: The Biotechnology Innovation Organization (BIO), a trade association representing biotechnology companies, supports the CMS Request for Information regarding PBM compensation and data collection. They advocate for broad definitions of PBM services and affiliates, strict "bona fide service fee" requirements, and extensive data reporting to ensure transparency and patient access to medicines.
Please see attached